Angiotensinogen mutations and risk for ischemic heart disease, myocardial infarction, and ischemic cerebrovascular disease

Annals of Internal Medicine

Volumn 134, Issue 10, 2001, Pages 941-954

  Sethi, Amar A ^a   Tybjærg Hansen, Anne ^a,b   Grønholdt, Marie Louise Moes ^a,b   Steffensen, Rolf ^a,c   Schnohr, Peter ^a,d   Nordestgaard, Børge G ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

^c Mental Health Services CPH   (Denmark)

^d BISPEBJERG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSINOGEN; COMPLEMENTARY DNA; CYTOSINE; HEART ENZYME; TYROSINE;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DENMARK; FEMALE; GENE; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HEART INFARCTION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK;

EID: 0342526616     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-134-10-200105150-00008     Document Type: Article

References (28)

1. Fauci A, Braunwald E, Isselbacher K, eds. Harrison's Principles of Internal Medicine. 14th ed. New York: McGraw-Hill; 1998.
2. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charm A, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell. 1992;71:169-80. [PMID: 1394429]
3. Katsuya T, Koike G, Yee TW, Sharpe N, Jackson R, Norton R, et al. Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet. 1995;345:1600-3. [PMID: 7783537]
4. Nakata Y, Katsuya T, Rakugi H, Takami S, Sato N, Kamide K, et al. Polymorphism of angiotensin converting enzyme, angiotensinogen, and apolipoprotein E genes in a Japanese population with cerebrovascular disease. Am J Hypertens. 1997;10:1391-5. [PMID: 9443775]
5. Ludwig EH, Borecki IB, Ellison RC, Folsom AR, Heiss G, Higgins M, et al. Associations between candidate loci angiotensin-converting enzyme and angiotensinogen with coronary heart disease and myocardial infarction: the NHLBI Family Heart Study. Ann Epidemiol. 1997;7:3-12. [PMID: 9034401]
6. Gardemann A, Stricker J, Humme J, Nguyen QD, Katz N, Philipp M, et al. Angiotensinogen T174M and M235T gene polymorphisms are associated with the extent of coronary atherosclerosis. Atherosclerosis. 1999;145:309-14. [PMID: 10488958]
7. Winkelmann BR, Russ AP, Nauck M, Klein B, Böhm BO, Maier V, et al. Angiotensinogen M235T polymorphism is associated with plasma angiotensinogen and cardiovascular disease. Am Heart J. 1999;137:698-705. [PMID: 10097233]
8. Tiret L, Ricard S, Poirier O, Arveiler D, Cambou JP, Luc G, et al. Genetic variation at the angiotensinogen locus in relation to high blood pressure and myocardial infarction: the ECTIM Study. J Hypertens. 1995;13:311-7. [PMID: 7622852]
9. Yamakawa-Kobayashi K, Arinami T, Hamaguchi H. Absence of association of angiotensinogen gene T235 allele with increased risk of coronary heart disease in Japanese [Letter], Lancet. 1995;346:515. [PMID: 7637519]
10. Barley J, Markus H, Brown M, Carter N. Lack of association between angiotensinogen polymorphism (M235T) and cerebrovascular disease and carotid atheroma. J Hum Hypertens. 1995;9:681-3. [PMID: 8523390]
11. Agerholm-Larsen B, Nordestgaard BG, Tybjaerg-Hansen A. ACE gene polymorphism in cardiovascular disease: meta-analyses of small and large studies in whites. Arterioscler Thromb Vasc Biol. 2000;20:484-92. [PMID: 10669647]
12. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-34. [PMID: 9310563]
13. Sethi AA, Nordestgaard BG, Agerhohn-Larsen B, Frandsen E, Jensen G, Tybjærg-Hansen A. Angiotensinogen polymorphisms and elevated blood pressure in the general population. The Copenhagen City Heart Study. Hypertension. 2001;37:875-81. [PMID: 0011244011].
14. Tybjaerg-Hansen A, Steffensen R, Meinertz H, Schnohr P, Nordestgaard BG. Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart disease. N Engl J Med. 1998;338:1577-84. [PMID: 9603795]
15. Nordestgaard BG, Abildgaard S, Wittrup HH, Steffensen R, Jensen G, Tybjaerg-Hansen A. Heterozygous lipoprotein lipase deficiency: frequency in the general population, effect on plasma lipid levels, and risk of ischemic heart disease. Circulation. 1997;96:1737-44. [PMID: 9323055]
16. Agerholm-Larsen B, Nordestgaard BG, Steffensen R, Sørensen TI, Jensen G, Tybjaerg-Hansen A. ACE gene polymorphism: ischemic heart disease and longevity in 10,150 individuals. A case-referent and retrospective cohort study based on the Copenhagen City Heart Study. Circulation. 1997;95:2358-67. [PMID: 9170397]
17. Wittrap HH, Tybjaerg-Hansen A, Abildgaard S, Steffensen R, Schnohr P, Nordestgaard BG. A common substitution (Asn291Ser) in lipoprotein lipase is associated with increased risk of ischemic heart disease. J Clin Invest. 1997;99: 1606-13. [PMID: 9120004]
18. Management of stable angina pectoris. Recommendations of the Task Force of the European Society of Cardiology. Eur Heart J. 1997;18:394-413. [PMID: 9076376]
19. Agerholm-Larsen B, Tybjaerg-Hansen A, Frikke-Schmidt R, Grønholdt ML, Jensen G, Nordestgaard BG. ACE gene polymorphism as a risk factor for ischemic cerebrovascular disease. Ann Intern Med. 1997;127:346-55. [PMID: 9273825]
20. Fukamizu A, Takahashi S, Seo MS, Tada M, Tanimoto K, Uehara S, et al. Structure and expression of the human angiotensinogen gene. Identification of a unique and highly active promoter. J Biol Chem. 1990;265:7576-82. [PMID: 1692023]
21. SPSS for Windows: Base System User's Guide & Professional Statistics. Release 8.0. Chicago: Norusis MJ/SPSS Inc; 1998.
22. Caulfield M, Lavender P, Farrall M, Munroe P, Lawson M, Turner P, et al. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med. 1994;330:1629-33. [PMID: 8177268]
23. Fornage M, Turner ST, Sing CF, Boerwinkle E. Variation at the M235T locus of the angiotensinogen gene and essential hypertension: a population-based case-control study from Rochester, Minnesota. Hum Genet. 1995;96:295-300. [PMID: 7649545]
24. Schunkert H, Hense HW, Gimenez-Roqueplo AP, Stieber J, Keil U, Riegger GA, et al. The angiotensinogen T235 variant and the use of antihypertensive drugs in a population-based cohort. Hypertension. 1997;29:628-33. [PMID: 9040449]
25. Tiret L, Blanc H, Ruidavets J, Arveiler D, Luc G, Jeunemaitre X, et al. Gene polymorphisms of the renin-angiotensin system in relation to hypertension and parental history of myocardial infarction and stroke: the PEGASE study. Projet d'Etude des Gènes de l'Hypertension Artérielle Sévère àmodérée Essentielle. J Hypertens. 1998;16:37-44. [PMID: 9533415]
26. Bloem LJ, Manatunga AK, Tewksbury DA, Pratt JH. The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children. J Clin Invest. 1995;95:948-53. [PMID: 7883995]
27. Staessen JA, Kuznetsova T, Wang JG, Emelianov D, Vlietinck R, Fagard R. M235T angiotensinogen gene polymorphism and cardiovascular renal risk. J Hypertens. 1999;17:9-17. [PMID: 10100088]
28. Kunz. R, Kreutz R, Beige J, Distler A, Sharma AM. Association between the angiotensinogen 235T-variant and essential hypertension in whites: a systematic review and methodological appraisal. Hypertension. 1997;30:1331-7. [PMID: 9403549]